Mark J. Gergen
2013 - Mirati Therapeutics
In 2013, Mark J. Gergen earned a total compensation of $1.4M as Executive Vice President and Chief Operations Officer at Mirati Therapeutics.
Compensation breakdown
Non-Equity Incentive Plan | $155,000 |
---|---|
Option Awards | $979,945 |
Salary | $311,539 |
Other | $3,120 |
Total | $1,449,604 |
Gergen received $979.9K in option awards, accounting for 68% of the total pay in 2013.
Gergen also received $155K in non-equity incentive plan, $311.5K in salary and $3.1K in other compensation.
Rankings
In 2013, Mark J. Gergen's compensation ranked 5,086th out of 12,286 executives tracked by ExecPay. In other words, Gergen earned more than 58.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,086 | 59th |
Manufacturing | 1,756 | 62nd |
Chemicals And Allied Products | 506 | 65th |
Drugs | 360 | 69th |
Pharmaceutical Preparations | 288 | 68th |
Gergen's colleagues
We found two more compensation records of executives who worked with Mark J. Gergen at Mirati Therapeutics in 2013.